Literature DB >> 6289178

Stereoselectivity of opiate antagonists in rat hippocampus and neocortex: responses to (+) and (-) isomers of naloxone.

T V Dunwiddie, E Perez-Reyes, K C Rice, M R Palmer.   

Abstract

The relative potencies of the (+) and (-) isomers of naloxone in antagonizing electrophysiological responses to D-alanine2-methionine enkephalinamide were compared in rat frontal cortex and hippocampus. In the in vitro hippocampus, the (-) isomer was found to be at least a 100 times more potent than the (+) isomer in antagonizing opiate-induced changes in field potentials. Similar stereoselectivity was observed in vivo in both frontal cortex and hippocampus in terms of the antagonism of enkephalin-induced changes in spontaneous cell firing. The direct effects of (+) and (-)-naloxone were examined as well. In hippocampus both in vivo and in vitro, no differential effect was observed, whereas in the neocortex (-)-naloxone was considerably more potent than the (+) isomer in eliciting depressions of spontaneous activity. These direct effects of naloxone in the cortex do not appear to be due to an antagonism of the effects of endogenously released opioids. These results demonstrate that the stereoselectivity of naloxone isomers in antagonizing electrophysiological responses to opiates in the cortex and hippocampus parallels that previously observed in other brain regions and in other tissues. In addition, they suggest that naloxone may have interactions with other unknown opiate (or possibly non-opiate) receptors which are of physiological significance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289178     DOI: 10.1016/0306-4522(82)90027-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

2.  Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.

Authors:  T V Dunwiddie; K J Johnson; W R Proctor
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

3.  Opioid activation of toll-like receptor 4 contributes to drug reinforcement.

Authors:  M R Hutchinson; A L Northcutt; T Hiranita; X Wang; S S Lewis; J Thomas; K van Steeg; T A Kopajtic; L C Loram; C Sfregola; E Galer; N E Miles; S T Bland; J Amat; R R Rozeske; T Maslanik; T R Chapman; K A Strand; M Fleshner; R K Bachtell; A A Somogyi; H Yin; J L Katz; K C Rice; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

4.  (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat.

Authors:  Maia Terashvili; Hsiang-en Wu; Rachel M Moore; David R Harder; Leon F Tseng
Journal:  Eur J Pharmacol       Date:  2007-06-05       Impact factor: 4.432

5.  Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.

Authors:  R Jackisch; M Geppert; A S Brenner; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.